CRVS logo
CRVS

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (CRVS) Earnings

Last reported
June 30, 2026
EPS Miss · -17.4%
EPS estimate
-$0.16
EPS actual
-$0.19
Revenue est.
—
Revenue actual
—